Page last updated: 2024-08-26

1,3,4-oxadiazole and Infections, Staphylococcal

1,3,4-oxadiazole has been researched along with Infections, Staphylococcal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Alghamadi, A; De Luca, L; Douglas, EJA; Duggan, S; Joseph, EA; Laabei, M; Marshall, B; Serpi, M; Vittorio, S1
Bao, C; Fan, J; Guo, Y; Liu, Z; Qin, S; Xu, T; Yang, R1

Other Studies

2 other study(ies) available for 1,3,4-oxadiazole and Infections, Staphylococcal

ArticleYear
Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict
    ACS infectious diseases, 2023, 11-10, Volume: 9, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Mammals; Methicillin-Resistant Staphylococcus aureus; Oxadiazoles; Staphylococcal Infections; Staphylococcus aureus

2023
Design and synthesis of new norfloxacin-1,3,4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA).
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2019, Aug-01, Volume: 136

    Topics: Animals; Anti-Bacterial Agents; Cell Line; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Norfloxacin; Oxadiazoles; Rats; Staphylococcal Infections; Structure-Activity Relationship; Vancomycin

2019